HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Experimental biofilm-related Candida infections.

AbstractAIM:
We investigated the pathogenic role of biofilm and the therapeutic efficacy of anidulafungin in experimental infections of the wax moth Galleria mellonella by Candida albicans clinical strains.
MATERIALS & METHODS:
On the basis of the in vitro propensity to form biofilm, five biofilm-producer (BP) and four nonproducer (NP) C. albicans clinical strains were used in this study. For each strain, we assessed the virulence by infecting G. mellonella larvae and observing survival. Anidulafungin was administered 2 h after yeast inoculum at 0.6 µg, according to the therapeutic dose recommended for humans.
RESULTS:
Biofilm-forming ability highly influenced the larva-killing rate. A significant (p < 0.0001) survival decrease was observed in the BP group, with 80% of the infected larvae dying within 72 h. NP isolates did not reach the same killing rate, even at the end of experiments (216 h). Larval survival was enhanced (p < 0.0001) by anidulafungin administration in both groups. Survival rate at 72 h was similar in both groups (BP 78.5% and NP 87.5%); whereas there were still differences at the end of the experiments, with a higher survival in the NP group (75 vs 48%).
CONCLUSION:
Our data confirm the pathogenic role of biofilm in C. albicans infections. Its importance was further enhanced by a lack of contribution from extracellular enzymes, detected in both NP and BP strains. In addition, we demonstrated anidulafungin efficacy in treating biofilm-related invasive candidiasis.
AuthorsDaniela Cirasola, Rita Sciota, Loredana Vizzini, Valentina Ricucci, Giulia Morace, Elisa Borghi
JournalFuture microbiology (Future Microbiol) Vol. 8 Issue 6 Pg. 799-805 (Jun 2013) ISSN: 1746-0921 [Electronic] England
PMID23701334 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
  • Echinocandins
  • Anidulafungin
Topics
  • Anidulafungin
  • Animals
  • Antifungal Agents (administration & dosage)
  • Biofilms (growth & development)
  • Candida albicans (pathogenicity, physiology)
  • Candidiasis (drug therapy, microbiology, pathology)
  • Disease Models, Animal
  • Echinocandins (administration & dosage)
  • Larva (microbiology)
  • Lepidoptera (growth & development, microbiology)
  • Survival Analysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: